Core Insights - The recent China-SCO (Belarus, Uzbekistan) International Medical and Pharmaceutical Industry Cooperation Conference held in Fangchenggang has led to multiple medical cooperation agreements among China, Belarus, and Uzbekistan [1][3] Group 1: Event Overview - The conference took place on November 26 in Fangchenggang, attended by numerous guests and pharmaceutical representatives from China, Belarus, and Uzbekistan [1] - A signing ceremony resulted in a memorandum of cooperation between the Fangchenggang International Medical Open Experimental Zone and the Belarus "Giant Stone" China-Belarus Industrial Park [3] Group 2: Key Agreements and Achievements - Strategic cooperation framework agreements were signed between the Fangchenggang International Medical Open Experimental Zone and Belarusian companies, focusing on traditional medicine development and personnel training [3] - The "Pearl Eye Drops," produced by Lezhu Pharmaceutical and registered in Belarus, marks a significant breakthrough for Chinese traditional medicine entering the SCO market [3] Group 3: Future Development and Collaboration - Fangchenggang aims to enhance its international medical cooperation with countries in the SCO, ASEAN, and Belt and Road Initiative, having established partnerships with various foreign industrial parks [5] - The Fangchenggang International Medical Open Experimental Zone is developing into a more open and inclusive platform, seeking to build international medical institutions and regional medical centers to provide healthcare services to SCO member states [6]